The weight-loss drug Belviq is being voluntarily withdrawn due to an increased risk in Cancer
Call now to find out if you qualify
In February 2020 the FDA issued a Safety Communication after clinical trials showed a possible increase in Cancer when using Belviq — and the drug is now being voluntarily withdrawn from the market.After the FDA received the results of the study and analyzed the information, it determined that more patients taking Belviq were diagnosed with cancer compared to patients taking a placebo.
Here is a link to the FDA recall notice: https://www.fda.gov/drugs/drug-safety-and-availability/fda-requests-withdrawal-weight-loss-drug-belviq-belviq-xr-lorcaserin-market
According to the FDA - "“We are taking this action because we believe that the risks of lorcaserin (Belviq) outweigh its benefits based on our completed review of results from a randomized clinical trial assessing safety.”"
Cancers associated with Belviq include, Colorectal, Pancreatic, Lung, along with many others.
If you or a loved one took the weight-loss drug Belviq and were later diagnosed with Cancer – call right now, you may be owed significant compensation from the manufacturer.
There are time deadlines to file a claim so don't wait - call right now.
If you or a loved one took Belviq and were then diagnosed with:
You may be entitled to significant compensation from the manufacturer.
There are time deadlines to file a claim so don’t wait – act now.
Do not stop taking a prescribed medication without first consulting your doctor. Discontinuing a prescribed medication without your doctor's advice can result in injury or death.